Tvardi Therapeutics Inc. Com
13F holders, Q2 2025 (June 30)7holders −28
1new positions
30sold out
$23.33avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Tvardi Therapeutics Inc. Com in their 13F filings, down 28 from Q1 2025. 1 opened new positions and 30 sold out. The largest holders were Duncan Williams Asset Management, LLC ($509K), LRI Investments, LLC ($2K) and Painted Porch Advisors LLC ($140).
- Company
- Tvardi Therapeutics Inc. Com
- CUSIP
- 140755208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $509K |
| Exits | 30 | $3.2M |
All 13F filers, Q1 2025 → Q2 2025: 21,831 shares bought and 211,036 shares sold, net −189,205 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Duncan Williams Asset Management, LLC | 0.16% | New | 21,830 | $509K |
| LRI Investments, LLC | 0.00% | Reduce -1.2% | 82 | $2K |
| Painted Porch Advisors LLC | 0.00% | Reduce -10.0% | 6 | $140 |
| Creative Financial Designs Inc. | 0.00% | No change | 6 | $140 |
| Farther Finance Advisors, LLC | 0.00% | No change | 3 | $70 |
| Cornerstone Planning Group LLC | 0.00% | Add +200.0% | 1 | $26 |
| Front Row Advisors LLC | 0.00% | Reduce -50.0% | 1 | $23 |
"% of holder's portfolio" is TVARDI THERAPEUTICS INC COM's weight in each manager's 13F, not the share of Tvardi Therapeutics Inc. Com the manager owns.